跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IBUPROFENO AUROVITAS 400 MG CAPSULAS BLANDAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
IBUPROFENO AUROVITAS 400 MG CAPSULAS BLANDAS EFG
Approved
STANDARD
IBUPROFENO AUROVITAS 400 MG CAPSULAS BLANDAS EFG
Aurovitas Spain, S.A.U.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 30, 2024
Approval ID
8ca14c808adcc076
Company
Aurovitas Spain, S.A.U.
Type
Standard
Approval Details
Approval Id
8ca14c808adcc076
Drug Cima Aemps Name
IBUPROFENO AUROVITAS 400 MG CAPSULAS BLANDAS EFG
Register Number
89989
Holder Company Name
Aurovitas Spain, S.A.U.
Marketing Company Name
Aurovitas Spain, S.A.U.
Authorization Date
2024-12-30
Dosage Form
CÁPSULA BLANDA
Dose
400 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Aurovitas Spain, S.A.U.
Active Ingredients
IBUPROFENO
400 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 30, 2024
Approval ID
8ca14c808adcc076
Type
Standard
Back to CIMA-AEMPS Approvals
